Advertisement

Multicenter clinical trial of implanted norethindrone pellets for long-acting contraception in women

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Long-acting, biodegradable, subcutaneous implants of fused pellets composed of norethindrone (NET) and pure cholestrol were evaluated in 50 healthy, normally menstruating volunteers from five clinics. Evaluation of serum NET levels indicated a steady release rate over the 6-cycle follow-up period. There were no serious local reactions to the pellets. Menstrual cycle length remained unchanged, but the incidence of intermenstrual bleeding and/or spotting was higher during the initial 2–3 months of pellet use. Following pellet removal menstrual cycle parameters returned to their pre-pellet implantation values. Serum gonadotropin assays indicated the incidence of ovulatory cycles increased over the follow-up period. No significant changes in serum lipoproteins, SMAC-12 or enzyme profiles were observed. Although women were advised to use additional methods of contraception, three became pregnant while using the implants. Fibrous tissue was noted to form around the pellets, thus limiting the release of NET. Additional trials of higher NET doses are being evaluated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gupta G.N.
        • Saxena B.B.
        • Landesmann R.
        • Ledger W.J.
        Subcutaneous bio-absorbable pellets of norethindrone for contraception in women: Phase I Clinical Study.
        Fertil Steril. 1984; 41: 726
        • Walls C.
        • Vose C.W.
        • Horth C.E.
        • Palmer R.F.
        Radioimmunoassay of plasma norethindrone after ethynodiol diacetate administration.
        J Steroid Biochem. 1977; 8: 167
        • Gupta G.N.
        Horrocks D.L. Organic Scintillators and Liquid Scintillation Counting. Academic Press, New York1977: 747
        • Croxatto H.B.
        • Diaz S.
        • Mirende P.
        Plasma levels of levonorgestrel in women during long-term use of Norplant.
        Contraception. 1981; 23: 197
        • Croxatto H.B.
        • Diaz S.
        • Quinteros E.
        • Simoneti L.
        • Kaplan E.
        • Rencoret R.
        • Martinez C.
        Clinical assessment of subdermal implant of megestrol acetate, d-norgestrel and norethindrone as a long-term contraception in women.
        Contraception. 1975; 12: 615